3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine

C105H106Br4F2N26O14S2 — CID 158513346

About 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine

3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine (PubChem CID 158513346) has the molecular formula C105H106Br4F2N26O14S2 and a molecular weight of 2377.92 g/mol. Its IUPAC name is 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine.

Molecular Properties

• Compound Name: 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine
• PubChem CID: 158513346
• Molecular Formula: C105H106Br4F2N26O14S2
• Molecular Weight: 2377.92 g/mol
• Exact Mass: 2372.45
• IUPAC Name: 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine
• SMILES: CCCc1ccc(-c2nnc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4F)cnc3C)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4F)cnc3N)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(Br)cnc3C)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(Br)cnc3N)o2)cc1.CN(Cc1ccc(C(=O)CNC(=O)c2nc(Br)cnc2N)cc1)C(=O)OC(C)(C)C.Nc1ncc(Br)nc1C(=O)O
• InChI: InChI=1S/C25H25FN4O3S.C24H24FN5O3S.C20H24BrN5O4.C16H15BrN4O.C15H14BrN5O.C5H4BrN3O2/c1-5-6-17-7-9-18(10-8-17)24-29-30-25(33-24)23-16(4)27-14-22(28-23)20-12-11-19(13-21(20)26)34(31,32)15(2)3;1-4-5-15-6-8-16(9-7-15)23-29-30-24(33-23)21-22(26)27-13-20(28-21)18-11-10-17(12-19(18)25)34(31,32)14(2)3;1-20(2,3)30-19(29)26(4)11-12-5-7-13(8-6-12)14(27)9-24-18(28)16-17(22)23-10-15(21)25-16;1-3-4-11-5-7-12(8-6-11)15-20-21-16(22-15)14-10(2)18-9-13(17)19-14;1-2-3-9-4-6-10(7-5-9)14-20-21-15(22-14)12-13(17)18-8-11(16)19-12;6-2-1-8-4(7)3(9-2)5(10)11/h7-15H,5-6H2,1-4H3;6-14H,4-5H2,1-3H3,(H2,26,27);5-8,10H,9,11H2,1-4H3,(H2,22,23)(H,24,28);5-9H,3-4H2,1-2H3;4-8H,2-3H2,1H3,(H2,17,18);1H,(H2,7,8)(H,10,11)
• InChIKey: HLIFMPUDFGQRLP-UHFFFAOYSA-N
• XLogP: 21.19
• TPSA: 595.73 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 37
• Rotatable Bonds: 29
• Heavy Atoms: 153
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2377.92
LogP ≤ 5	21.19
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	37

Frequently Asked Questions

What is the IUPAC name of 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine?

The IUPAC name of 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine (CID 158513346) is 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine.

What is the SMILES notation for 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine?

The canonical SMILES for 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine is CCCc1ccc(-c2nnc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4F)cnc3C)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4F)cnc3N)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(Br)cnc3C)o2)cc1.CCCc1ccc(-c2nnc(-c3nc(Br)cnc3N)o2)cc1.CN(Cc1ccc(C(=O)CNC(=O)c2nc(Br)cnc2N)cc1)C(=O)OC(C)(C)C.Nc1ncc(Br)nc1C(=O)O.

What is the InChIKey of 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine?

The InChIKey is HLIFMPUDFGQRLP-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25FN4O3S.C24H24FN5O3S.C20H24BrN5O4.C16H15BrN4O.C15H14BrN5O.C5H4BrN3O2/c1-5-6-17-7-9-18(10-8-17)24-29-30-25(33-24)23-16(4)27-14-22(28-23)20-12-11-19(13-21(20)26)34(31,32)15(2)3;1-4-5-15-6-8-16(9-7-15)23-29-30-24(33-23)21-22(26)27-13-20(28-21)18-11-10-17(12-19(18)25)34(31,32)14(2)3;1-20(2,3)30-19(29)26(4)11-12-5-7-13(8-6-12)14(27)9-24-18(28)16-17(22)23-10-15(21)25-16;1-3-4-11-5-7-12(8-6-11)15-20-21-16(22-15)14-10(2)18-9-13(17)19-14;1-2-3-9-4-6-10(7-5-9)14-20-21-15(22-14)12-13(17)18-8-11(16)19-12;6-2-1-8-4(7)3(9-2)5(10)11/h7-15H,5-6H2,1-4H3;6-14H,4-5H2,1-3H3,(H2,26,27);5-8,10H,9,11H2,1-4H3,(H2,22,23)(H,24,28);5-9H,3-4H2,1-2H3;4-8H,2-3H2,1H3,(H2,17,18);1H,(H2,7,8)(H,10,11).

What are the key properties of 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine?

3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine has a molecular weight of 2377.92 g/mol, XLogP of 21.19, 29 rotatable bonds, 6 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 3-amino-6-bromopyrazine-2-carboxylic acid;2-(6-bromo-3-methylpyrazin-2-yl)-5-(4-propylphenyl)-1,3,4-oxadiazole;5-bromo-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine;tert-butyl N-[[4-[2-[(3-amino-6-bromopyrazine-2-carbonyl)amino]acetyl]phenyl]methyl]-N-methylcarbamate;2-[6-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-methylpyrazin-2-yl]-5-(4-propylphenyl)-1,3,4-oxadiazole;5-(2-fluoro-4-propan-2-ylsulfonylphenyl)-3-[5-(4-propylphenyl)-1,3,4-oxadiazol-2-yl]pyrazin-2-amine is sourced from PubChem (CID 158513346), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).